Core One Labs Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLABF research report →
About the company
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin.
- CEO
- Gareth Manderson
- IPO
- 2015
- Employees
- 192
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $471
- P/E
- -0.28
- P/S
- 14.89
- P/B
- 0.66
- EV/EBITDA
- -0.41
- Div Yield
- 0.00%
- Gross Margin
- 90.80%
- Op Margin
- -1709.20%
- Net Margin
- -3485.36%
- ROE
- -289.95%
- ROIC
- -112.04%
- Revenue
- $458.54K · 6.24%
- Net Income
- $-15,981,819 · 56.87%
- EPS
- $-0.49 · 80.93%
- Op Income
- $-7,837,370
- FCF YoY
- 39.80%
- 52W High
- $0.06
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.49
- Avg Volume
- 42.72K
Get TickerSpark's AI analysis on CLABF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CLABF coverage
Recent articles, reports, and earnings notes.
No research on CLABF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLABF report →Similar companies
Peers in the same neighborhood.